Research/P-04
P-04Muscle28 studies indexed

Follistatin 344

Removes the brake on muscle growth.

By HelixHouse Research TeamPublished Last reviewed
01 · Overview

Follistatin is a naturally-occurring protein that binds and neutralizes myostatin, the primary negative regulator of muscle growth. Follistatin-344 is a specific 344-amino-acid isoform researched for its systemic bioavailability. Animals genetically lacking myostatin (double-muscled cattle, mice) exhibit dramatic musculature, which is what drove interest in follistatin as a hypertrophy tool.

02 · Mechanism of Action

High-affinity binding to myostatin (GDF-8) prevents it from activating the ActRIIB receptor on muscle cells. This removes the natural brake on satellite cell activation and protein synthesis. Also inhibits activin A, which contributes to muscle wasting in disease states.

03 · Current Evidence
  • E.01Preclinical models show significant lean mass gains and strength increases after follistatin overexpression.
  • E.02Gene therapy trials (AAV-follistatin) have shown early promise for muscular dystrophy patients.
  • E.03Direct peptide use in humans is anecdotal — no large-scale trials of exogenous follistatin-344 protein.
04 · Reported Benefits
B.01Accelerated lean muscle hypertrophy
B.02Breaking through hard training plateaus
B.03Improved strength gains alongside standard training
05 · Safety Considerations

Long-term systemic myostatin inhibition is not without risk — myostatin plays roles beyond muscle regulation (tendon strength, metabolic signaling). Excessive muscle mass without proportional tendon adaptation may raise injury risk. Not FDA-approved.

06 · Common Stacks

Advanced users stack with growth hormone secretagogues (CJC-1295 / Ipamorelin) or IGF-1 LR3 during hypertrophy phases.

07 · Regulatory Status

Research use only. Not FDA-approved.

08 · References & Further Reading
R.01
Myostatin inhibition in muscle, but not adipose tissue
PLOS ONE (2009)
↗
R.02
Follistatin gene therapy improves muscle mass and function
Molecular Therapy (2009)
↗
R.03
Myostatin and its inhibitors: therapeutic potential
Journal of Endocrinology (2020)
↗
09 · Frequently Asked Questions
How does Follistatin 344 work?+
High-affinity binding to myostatin (GDF-8) prevents it from activating the ActRIIB receptor on muscle cells. This removes the natural brake on satellite cell activation and protein synthesis. Also inhibits activin A, which contributes to muscle wasting in disease states.
What are the reported benefits of Follistatin 344?+
Accelerated lean muscle hypertrophy Breaking through hard training plateaus Improved strength gains alongside standard training Note: reported benefits vary and much of the evidence is preclinical.
Is Follistatin 344 safe?+
Long-term systemic myostatin inhibition is not without risk — myostatin plays roles beyond muscle regulation (tendon strength, metabolic signaling). Excessive muscle mass without proportional tendon adaptation may raise injury risk. Not FDA-approved.
What is the regulatory status of Follistatin 344?+
Research use only. Not FDA-approved.
Educational content only · Reviewed July 8, 2026 by HelixHouse Research Team

This page summarizes publicly available research. Nothing here is medical advice, a prescription, or a diagnosis. Peptides described are not FDA-approved for the uses discussed unless explicitly noted. Consult a qualified physician before starting any protocol.